SCHEMBL12700355

SCHEMBL12700355

COc1ccc(NC(=O)c2cc(Cl)c(Cl)cc2C(=O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.60
KMT2A Q03164 5/20 0.60
MAPT P10636 2/20 0.60
TAS1R3 Q7RTX0 1/20 0.59
TAS1R1 Q7RTX1 1/20 0.59
TAS1R2 Q8TE23 1/20 0.59
GRIK1 P39086 1/20 0.56
TYK2 P29597 2/20 0.56
JAK2 O60674 1/20 0.56
SORT1 Q99523 1/20 0.56
NPC1 O15118 5/20 0.55
RAB9A P51151 4/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
TP53 P04637 1/20 0.55
ALOX15 P16050 1/20 0.55
GAA P10253 2/20 0.55
POLB P06746 1/20 0.55
CASP3 P42574 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12189614 0.84 STK39 (0.66) MEN1KMT2AALDH1A1
SCHEMBL12700212 0.83 SORT1 (0.58) MEN1KMT2AMAPTGRIK1TYK2
SCHEMBL16426253 0.82 MEN1 (0.54) MEN1KMT2ATYK2JAK2SORT1
SCHEMBL11887699 0.81 SORT1 (0.57) MEN1KMT2AMAPTGRIK1SORT1
SCHEMBL10489750 0.81 NPC1 (0.60) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL10489747 0.81 NPC1 (0.60) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL24733339 0.81 ALDH1A1 (0.65) MEN1KMT2AMAPTSORT1SMN1; SMN2
SCHEMBL16168001 0.80 MEN1 (0.53) MEN1KMT2ASORT1KDM4E
SCHEMBL12189549 0.80 NPC1 (0.72) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL18132377 0.79 NR1H4 (0.58) MEN1KMT2AMAPTSORT1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10166237-B2 Compounds and methods for inducing chondrogenesis THE SCRIPPS RESEARCH INSTITUTE (US) 2019-01-01 US disclosed
US-20170112843-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE SCRIPPS RESEARCH INSTITUTE 2017-04-27 US disclosed
US-9464065-B2 Compounds and methods for inducing chondrogenesis THE SCRIPPS RESEARCH INSTITUTE (US) 2016-10-11 US disclosed
WO-2012129562-A2 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE SCRIPPS RESEARCH INSTITUTE (US) 2012-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10166237-B2 Compounds and methods for inducing chondrogenesis COL2A1, BMP4, BMP2 MEN1 4660/4885KMT2A 3000/4885MAPT 4575/4885
US-20170112843-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS COL2A1, BMP4, BMP2 MEN1 4660/4885KMT2A 3000/4885MAPT 4575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.